Interaction Between Vitamin D and Interleukin 6 on Slow Gait Speed: 6-Year Follow-up Data of Older Adults From InCHIANTI.
Gait Speed
IL-6
Interaction
Vitamin D
Journal
The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837
Informations de publication
Date de publication:
22 05 2020
22 05 2020
Historique:
received:
30
07
2018
pubmed:
10
7
2019
medline:
2
2
2021
entrez:
9
7
2019
Statut:
ppublish
Résumé
Whereas the independent effects of biomarkers, including 25-hydroxy vitamin D (25(OH)D), insulin-like growth factor 1, C-reactive protein, and interleukin 6 (IL-6), on gait speed in older adults have been evaluated, their joint effects on gait speed are not well understood. Study subjects aged at least 65 at baseline (N = 970) were enrolled in the population-based Invecchiare in Chianti (InCHIANTI) study from 1998 to 2000 and were followed up at 3 and 6 years. All above biomarkers and gait speed data were measured at each of the three time points. Using a generalized estimating equation approach, we determined if slow gait speed (<0.8 m/s) was associated with the biomarkers. Further investigation was conducted for interactions between high IL-6 (≥.87 pg/mL) and other biomarkers focusing on low 25(OH)D (<20 ng/mL). After controlling for other biomarkers and potential confounders, IL-6 emerged as the only biomarker independently associated with gait speed. The association between high IL-6 and slow gait speed was enhanced by low 25(OH)D, with significant interaction between high IL-6 and low 25(OH)D (p = .038). The odds ratio of slow gait speed for low 25(OH)D and high IL-6 was 1.63 (95% confidence interval [CI]: 1.15, 2.32) compared with the reference groups with both biomarker levels at the other ends. The association of low vitamin D with slow gait speed statistically interacts with high IL-6. Coexisting vitamin D insufficiency and inflammation may provide a better biomarker for identifying those at risk of developing impairments in gait speed than either factor alone.
Sections du résumé
BACKGROUND
Whereas the independent effects of biomarkers, including 25-hydroxy vitamin D (25(OH)D), insulin-like growth factor 1, C-reactive protein, and interleukin 6 (IL-6), on gait speed in older adults have been evaluated, their joint effects on gait speed are not well understood.
METHODS
Study subjects aged at least 65 at baseline (N = 970) were enrolled in the population-based Invecchiare in Chianti (InCHIANTI) study from 1998 to 2000 and were followed up at 3 and 6 years. All above biomarkers and gait speed data were measured at each of the three time points. Using a generalized estimating equation approach, we determined if slow gait speed (<0.8 m/s) was associated with the biomarkers. Further investigation was conducted for interactions between high IL-6 (≥.87 pg/mL) and other biomarkers focusing on low 25(OH)D (<20 ng/mL).
RESULTS
After controlling for other biomarkers and potential confounders, IL-6 emerged as the only biomarker independently associated with gait speed. The association between high IL-6 and slow gait speed was enhanced by low 25(OH)D, with significant interaction between high IL-6 and low 25(OH)D (p = .038). The odds ratio of slow gait speed for low 25(OH)D and high IL-6 was 1.63 (95% confidence interval [CI]: 1.15, 2.32) compared with the reference groups with both biomarker levels at the other ends.
CONCLUSION
The association of low vitamin D with slow gait speed statistically interacts with high IL-6. Coexisting vitamin D insufficiency and inflammation may provide a better biomarker for identifying those at risk of developing impairments in gait speed than either factor alone.
Identifiants
pubmed: 31282535
pii: 5529486
doi: 10.1093/gerona/glz165
pmc: PMC7243581
doi:
Substances chimiques
Biomarkers
0
IGF1 protein, human
0
Interleukin-6
0
Vitamin D
1406-16-2
Insulin-Like Growth Factor I
67763-96-6
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1161-1166Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
J Clin Endocrinol Metab. 2011 Jan;96(1):53-8
pubmed: 21118827
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):242-8
pubmed: 15031308
Osteoporos Int. 2018 Mar;29(3):579-586
pubmed: 29260292
J Am Geriatr Soc. 2000 Dec;48(12):1618-25
pubmed: 11129752
JAMA Intern Med. 2015 May;175(5):703-11
pubmed: 25799402
Calcif Tissue Int. 2018 Mar;102(3):287-295
pubmed: 29101476
JAMA. 2017 Nov 7;318(17):1687-1699
pubmed: 29114830
J Nutr Health Aging. 2017;21(9):936-942
pubmed: 29083433
BMC Musculoskelet Disord. 2015 Aug 19;16:202
pubmed: 26286594
JAMA. 2011 Jan 5;305(1):50-8
pubmed: 21205966
J Am Geriatr Soc. 2007 May;55(5):780-91
pubmed: 17493201
J Nutr Health Aging. 2009 Dec;13(10):893-8
pubmed: 19924350
J Physiol. 2017 Nov 15;595(22):6825-6836
pubmed: 28949008
J Am Geriatr Soc. 2013 Sep;61(9):1574-9
pubmed: 23927858
Age (Dordr). 2014;36(4):9694
pubmed: 25086618
PLoS One. 2018 Jan 3;13(1):e0190410
pubmed: 29298330
J Clin Endocrinol Metab. 2003 May;88(5):2019-25
pubmed: 12727948
J Gerontol A Biol Sci Med Sci. 2016 Jun;71(6):797-802
pubmed: 26424830
Exp Gerontol. 2018 Jan;101:1-6
pubmed: 29137947
Age (Dordr). 2013 Jun;35(3):963-71
pubmed: 22388931
J Clin Endocrinol Metab. 2011 Oct;96(10):2987-96
pubmed: 21795456
J Steroid Biochem Mol Biol. 2009 Jan;113(1-2):134-8
pubmed: 19138739
J Gerontol A Biol Sci Med Sci. 2015 Apr;70(4):525-31
pubmed: 25112493
Mol Aspects Med. 2005 Jun;26(3):181-201
pubmed: 15811434
Exp Gerontol. 2017 Dec 1;99:115-119
pubmed: 28987642
Am J Clin Nutr. 2011 May;93(5):1006-11
pubmed: 21411617
Kidney Int. 2007 Apr;71(8):730-7
pubmed: 17332731
J Am Geriatr Soc. 2011 Oct;59(10):1793-801
pubmed: 22091492
JAMA. 2017 Dec 26;318(24):2466-2482
pubmed: 29279934
Hypertension. 2011 Jan;57(1):63-9
pubmed: 21115878
J Gerontol A Biol Sci Med Sci. 2018 May 9;73(6):770-778
pubmed: 29304217
J Gerontol A Biol Sci Med Sci. 2017 Dec 12;73(1):95-101
pubmed: 28977347
Int J Epidemiol. 2016 Aug;45(4):1135-1145
pubmed: 27272182
Rejuvenation Res. 2010 Feb;13(1):3-11
pubmed: 20230273
Diabetes Care. 2011 Oct;34(10):2320-2
pubmed: 21873558
Maturitas. 2017 Dec;106:8-25
pubmed: 29150169
Endocrinol Metab Clin North Am. 2017 Dec;46(4):919-933
pubmed: 29080643
J Clin Endocrinol Metab. 2011 Oct;96(10):2997-3006
pubmed: 21795448
Arch Intern Med. 2007 Nov 12;167(20):2249-54
pubmed: 17998499
J Gerontol A Biol Sci Med Sci. 2007 Apr;62(4):440-6
pubmed: 17452740